Tempong, Jerome F.
HRN: 05-27-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/11/2024
03/17/2024
IVT
500mg
OD
CAP MR; S/p Tracheostomy
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes